NCT00671320View on ClinicalTrials.gov

A Multi-Center, Randomized, Double-Blind, Parallel Group Study To Compare The Efficacy And Tolerability Of Valdecoxib And Diclofenac In Patients With A Sprained Ankle

PHASE4CompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

December 31, 2002

Study Completion Date

October 31, 2003

Conditions
PainSprains and StrainsSprain
Interventions
DRUG

valdecoxib

valdecoxib 40 mg tablet by mouth twice daily (BID) on Day 1 and then once daily (QD) on Days 2 to 7

DRUG

diclofenac

diclofenac 75 mg capsule by mouth twice daily (BID) for 7 days

Trial Locations (15)

27

Pfizer Investigational Site, Lima

1642

Pfizer Investigational Site, San Isidro

1872

Pfizer Investigational Site, Avellaneda

64460

Pfizer Investigational Site, Monterrey

Unknown

Pfizer Investigational Site, Buenos Aires

Pfizer Investigational Site, Santiago

Pfizer Investigational Site, Santiago

Pfizer Investigational Site, Lima

(574) 5141516

Pfizer Investigational Site, Medellín

(57) 310-2322198

Pfizer Investigational Site, Bogota

(57) 310-8849622

Pfizer Investigational Site, Bogota

(571) 6 164278

Pfizer Investigational Site, Bogotá

(577) 6 395409

Pfizer Investigational Site, Bucaramanga

(57) 310-8259712

Pfizer Investigational Site, Calli

(57) 315-5410469

Pfizer Investigational Site, Santiago de Cali

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY